ARS Pharmaceuticals (SPRY) Prepaid Assets (2020 - 2026)

ARS Pharmaceuticals has reported Prepaid Assets for 7 years, with the latest figure at $6.8 million in Q1 2026.

• Quarterly Prepaid Assets fell 41.28% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (down 41.28% YoY) and the FY2025 annual result came in at $6.2 million, down 10.05% from the prior year.
• Prepaid Assets rose to $6.8 million in Q1 2026 per SPRY's latest filing, from $6.2 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $11.6 million in Q1 2025 and troughed at $137000.0 in Q3 2024.
• A 5-year average of $3.8 million and a median of $3.3 million in 2022 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2025: Prepaid Assets sank 86.75% in 2024, then jumped 4586.86% in 2025.
• Over 5 years, Prepaid Assets stood at $3.3 million in 2022, then tumbled by 66.13% to $1.1 million in 2023, then surged by 512.63% to $6.9 million in 2024, then decreased by 10.05% to $6.2 million in 2025, then increased by 9.59% to $6.8 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $6.8 million, $6.2 million, and $6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.